Notices. Notice
207 words·~1 min read·
/register/2015/11/23/2015-29778A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 3510-60-P DEPARTMENT OF THE ARMY Intent To Grant an Exclusive License of U.S. Government-Owned Patents AGENCY: Department of the Army, DoD. ACTION: Notice. SUMMARY: In accordance with 35 U.S.C. 209
(e)and 37 CFR 404.7 (a)(1)(i), announcement is made of the intent to grant an exclusive, royalty-bearing, revocable license to US Provisional Patent Application 62/131,444, filed March 11, 2015, entitled, “A method for developing malaria sporozoites *in vitro”* to MalarVx, Inc., a for profit corporation, having a principal place of business at 307 Westlake Avenue North, Suite 200, Seattle, WA 98109. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, MD 21702-5012. FOR FURTHER INFORMATION CONTACT: For licensing issues, Mr. Barry Datlof, Office of Research & Technology Assessment,
(301)619-0033. For patent issues, Ms. Elizabeth Arwine, Patent Attorney,
(301)619-7808, both at telefax
(301)619-5034. SUPPLEMENTARY INFORMATION: Anyone wishing to object to the grant of this license can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Command Judge Advocate (see ADDRESSES ). Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2015-29778 Filed 11-20-15; 8:45 am]
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources